Skip to main content
Clinical Trials/NCT01195441
NCT01195441
Completed
Not Applicable

Prediction and Prevention of Preeclampsia by First Trimester Ultrasound

Norwegian University of Science and Technology1 site in 1 country602 target enrollmentSeptember 2010
ConditionsPreeclampsia

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Preeclampsia
Sponsor
Norwegian University of Science and Technology
Enrollment
602
Locations
1
Primary Endpoint
Development of preeclampsia
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

The purpose of this study is to determine whether the Fetal Medicine Foundation algorithm for individual risk calculation for preeclampsia (PE) and pregnancy induced hypertension (PIH) is suitable to identify women in high risk of developing these diseases in a Norwegian population.

Detailed Description

It has been shown that low dose acetylsalicylic acid (ASA) in pregnancy reduces adverse outcome of pregnancy in women that have high risk of developing preeclampsia (PE). It is a challenge for the clinician to identify the high risk women. Doppler blood flow measurements in uterine arteries in second trimester have been shown useful to predict the development of the disease but prophylactic treatment with ASA from this point in pregnancy has not been proven effective. Fetal Medical Foundation has developed an algorithm that calculates individual risks for PE/ PIH based on Doppler blood flow measurements and anamnestic information.

Registry
clinicaltrials.gov
Start Date
September 2010
End Date
October 2013
Last Updated
9 years ago
Study Type
Observational
Sex
Female

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Nulliparous
  • Para 1+ with previous preeclampsia or gestational hypertension
  • last menstrual period (LMP) pregnancy length at inclusion \< 13 weeks
  • Residence in Trondheim + 8 surrounding municipalities

Exclusion Criteria

  • Pregnancy length \> 13+6 weeks (CRL \> 85 mm)
  • Missed abortion
  • Fetal anomaly

Outcomes

Primary Outcomes

Development of preeclampsia

Time Frame: september 2012

Onset time of preeclampsia

Time Frame: September 2012

Secondary Outcomes

  • Gestational age at delivery(September 2012)
  • Number of induction of deliveries due to preeclampsia(September 2010)
  • Maternal morbidity(September 2012)
  • Perinatal morbidity(September 2012)
  • Number of instrumental deliveries due to preeclampsia(September 2012)

Study Sites (1)

Loading locations...

Similar Trials